Description
| Product Name | CAT.No | Size |
| Anti-FYb | BGFYB002 | 1 x 2ml |
Product Description
The Biorex Diagnostics Anti-FYb reagent is a ready-to-use monoclonal antibody solution specifically designed for the accurate detection of the FYb antigen in the Duffy blood group system on human red blood cells. The FYb antigen is clinically significant because antibodies formed against it can lead to haemolytic transfusion reactions (HTRs) and haemolytic disease of the newborn (HDN). Precise identification of FYb is therefore critical to ensure safe transfusion practices, extended phenotyping, and comprehensive antibody investigations in hospital laboratories, blood banks, and reference immunohaematology facilities.
Key Features
- Accurate FYb antigen detection – clearly identifies FYb-positive and FYb-negative red cells, supporting reliable donor and patient typing.
- Indirect antiglobulin test (IAT) – provides sensitive and reproducible detection of clinically significant antibodies, including those present in low titres.
- Clinically significant – assists in preventing HTRs and HDN associated with anti-FYb antibodies, contributing to safer transfusion outcomes.
- Ready-to-use format – supplied as a stable liquid reagent, eliminating the need for dilution or preparation and reducing laboratory errors.
- Consistent monoclonal performance – ensures reliable and repeatable results across multiple samples, even in complex antibody screening scenarios.
Benefits
Routine use of the Anti-FYb reagent enables laboratories to accurately determine the FYb antigen status of both donor and patient red cells, improving transfusion safety and supporting extended immunohaematology panels. Its ready-to-use format streamlines workflow, reduces handling errors, and saves valuable laboratory time, while the high specificity and sensitivity of the monoclonal antibodies ensure dependable detection in both routine and advanced testing.
The reagent is highly valuable for the identification of clinically significant antibodies in complex antibody investigations, helping laboratories prevent alloimmunisation in sensitised patients and select compatible blood for transfusion. Incorporating the Biorex Anti-FYb reagent into standard immunohaematology protocols enhances patient safety, facilitates extended blood group phenotyping, and supports the accurate management of HTRs and HDN risk. Its precision, reproducibility, and ease of use make it an essential tool for hospital laboratories, blood banks, and specialist transfusion services, providing confidence in laboratory results and ensuring effective patient care.
Contact Us for more information.